All articles by Nikki Thompson

The growing role of CDMOs in the circular economy

Sustainability in the 21st century is an essential component of business operations. With regard to environmental stewardship, new regulations in…
Healing begins with research: Promising development program on stem cells in rare diseases

Despite their potential to revolutionise medicine, stem cell therapies have long faced scepticism within the pharmaceutical industry. Concerns about the…
Advancing Pharmaceutical Security: The Role of SECURtracers in On-Dose Authentication

On-dose authentication, the practice of integrating traceable markers directly into or onto pharmaceutical products, is yet to be implemented within…
Pioneering ePRO and eCOA innovations for next-generation clinical trials

The pharmaceutical industry is undergoing a major transformation, as clinical trials become increasingly data heavy and digital-based. Traditional methods of…
Combating Pharmaceutical Crime with On-Dose Authentication

Despite the best efforts of pharmaceutical manufacturers and regulators to improve the security and traceability of drug products, counterfeits continue…

How to optimize efficiencies at site-centric clinical trials

The global clinical trials landscape has transformed significantly over the past five years. The Covid-19 pandemic accelerated the rapid adoption…
Chronic Lymphocytic Leukaemia: the global clinical trials landscape in 2024

Chronic lymphocytic leukaemia is a slow-growing leukaemia characterised by the accumulation of dysfunctional B lymphocytes, primarily affecting older adults. Its…
Understanding ICH Guideline Q14

The latest ICH guideline, Q14, complements Q2(R2) for the validation of analytical procedures. Revision of Q2(R1) into Q2(R2) aligns its…
Q&A with Springer Nature’s Leslie Lansman: Ethical content sharing and the benefits of the CLA Pharmaceutical Licence

The pharmaceutical and medical communications industry relies heavily on the use and dissemination of scientific journals, research papers, medical reports,…
ePRO vs eCOA: Understanding the nuances in clinical trials

Two such tools – electronic patient-reported outcomes (ePRO) and electronic clinical outcomes assessments (eCOA) – are often mentioned together. However,…